Selected article for: "residual infectivity and wide range"
Author: Gröner, Albrecht; Broumis, Connie; Fang, Randel; Nowak, Thomas; Popp, Birgit; Schäfer, Wolfram; Roth, Nathan J.
Title: Effective inactivation of a wide range of viruses by pasteurization
  • Document date: 2017_11_16
    • ID: w19hl2vs_17
    Snippet: HSA is not stabilized by components affecting the inactivation kinetics of a range of viruses but only by caprylate and N-acetyltryptophan. An effective (i.e., virus RFs in the order of 4 log or greater) virus reduction capacity could be demonstrated for the viruses studied covering a wide range of human pathogenic viruses or their specific model viruses; no residual infectivity was observed at the latest after 6 hours of pasteurization. The anim.....
    Document: HSA is not stabilized by components affecting the inactivation kinetics of a range of viruses but only by caprylate and N-acetyltryptophan. An effective (i.e., virus RFs in the order of 4 log or greater) virus reduction capacity could be demonstrated for the viruses studied covering a wide range of human pathogenic viruses or their specific model viruses; no residual infectivity was observed at the latest after 6 hours of pasteurization. The animal parvovirus, CPV, showed resistance to heat treatment, in contrast to the relevant human pathogenic virus B19V (Table 2) .

    Search related documents:
    Co phrase search for related documents
    • animal parvovirus and residual infectivity: 1
    • animal parvovirus and treatment heat: 1
    • CPV animal parvovirus and residual infectivity: 1
    • CPV animal parvovirus and treatment heat: 1
    • human pathogenic virus and model virus: 1, 2, 3, 4, 5, 6
    • human pathogenic virus and pathogenic virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • human pathogenic virus and virus range: 1
    • human pathogenic virus and virus reduction: 1, 2, 3, 4, 5, 6
    • human pathogenic virus and wide range: 1, 2
    • inactivation kinetic and model virus: 1
    • inactivation kinetic and residual infectivity: 1, 2, 3
    • inactivation kinetic and treatment heat: 1
    • inactivation kinetic and virus range: 1
    • inactivation kinetic and virus reduction: 1, 2
    • inactivation kinetic and virus rf: 1, 2
    • model virus and pathogenic virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • model virus and residual infectivity: 1, 2, 3
    • model virus and specific model virus: 1, 2, 3, 4, 5, 6, 7
    • model virus and treatment heat: 1, 2, 3, 4, 5, 6